These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4289746)

  • 1. Virus particles and murine leukemia virus complement-fixing antigen in neoplastic and nonneoplastic cell lines.
    Hall WT; Andresen WF; Sanford KK; Evans VJ; Hartley JW
    Science; 1967 Apr; 156(3771):85-8. PubMed ID: 4289746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement fixation in conventional and regressing virus-induced murine leukemia.
    Rich MA; Karl S; Clymer R
    J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo observations on a murine C-type virus.
    Hall WT; Andresen WF; Evans VJ
    J Virol; 1967 Dec; 1(6):1238-54. PubMed ID: 4316251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement fixation and tissue culture assays for mouse leukemia viruses.
    Hartley JW; Rowe WP; Capps WI; Huebner RJ
    Proc Natl Acad Sci U S A; 1965 May; 53(5):931-8. PubMed ID: 4287967
    [No Abstract]   [Full Text] [Related]  

  • 5. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
    Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
    J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus.
    Rowe WP; Hartley JW; Lander MR; Pugh WE; Teich N
    Virology; 1971 Dec; 46(3):866-76. PubMed ID: 4332980
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-producer human cells induced by murine sarcoma virus.
    Rhim JS; Cho HY; Huebner RJ
    Int J Cancer; 1975 Jan; 15(1):23-9. PubMed ID: 165148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration by Diaflo ultrafiltration of murine leukemia and sarcoma viruses grown in tissue cultures.
    Rhim JS; Williams LB; Huebner RJ; Turner HC
    Cancer Res; 1969 Jan; 29(1):154-6. PubMed ID: 4303443
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of and relationship between C particles and intracisternal A particles in cloned cell strains.
    Hall WT; Hartley JW; Sanford KK
    J Virol; 1968 Mar; 2(3):238-47. PubMed ID: 4316022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO
    Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
    [No Abstract]   [Full Text] [Related]  

  • 13. Murine leukemia viruses: antigenic studies by quantitative complement fixation.
    Gerber P; O'Connor TE; Birch SM
    Science; 1966 May; 152(3725):1074-5. PubMed ID: 4286616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous transformation of rat cells after long-term in vitro cultivation and the "switch-on" of a new complement-fixing antigen.
    Rhim JS; Vernon ML; Huebner RJ; Turner HC; Lane WT; Gilden RV
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):414-9. PubMed ID: 4338795
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines.
    Chesebro B; Wehrly K; Chesebro K; Portis J
    J Immunol; 1976 Oct; 117(4):1267-74. PubMed ID: 185295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses.
    Yoshiki T; Mellors RC; Hardy WD
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1878-82. PubMed ID: 4352660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens.
    Treves AJ; Feldman M; Kaplan HS
    J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat embryo cells in complement fixation tests for murine leukemia virus.
    Rhim JS; Huebner RJ
    Nature; 1970 May; 226(5246):646-7. PubMed ID: 4315549
    [No Abstract]   [Full Text] [Related]  

  • 19. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.